Market Forecast By Drug Type (Prescription Drugs, OTC Drugs), By Type (Community Pharmacy, Hospital Pharmacy, Clinical Pharmacy, Industrial Pharmacy, Compounding Pharmacy, Consulting Pharmacy, Ambulatory Care Pharmacy, Others) And Competitive Landscape
Product Code: ETC036198 | Publication Date: Jun 2023 | Updated Date: Jan 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Report Name | Kazakhstan Pharmacies and Drug Stores market |
Forecast period | 2025-2031 |
Forecast size | USD 2.6 Billion – USD 3.8 Billion |
CAGR | 7.9% |
Growing Sector | Healthcare |
The Kazakhstan Pharmacies and Drug Stores market report thoroughly covers the market by drug type and by type. The report provides an unbiased and detailed analysis of the on-going market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
In 2024, the Kazakhstan Pharmacies and Drug Stores market is valued at approximately $ 2.6 billion, with a projected compound annual growth rate (CAGR) of 7.9% over the next five years. Additionally, by 2030, the market is expected to reach around $ 3.8 billion. The healthcare sector holds significant position in the overall market.
The pharmacies and drug stores market in Kazakhstan is growing rapidly, driven by an increasing demand for healthcare services, an expanding middle class, and rising awareness about health and wellness. With a population of over 19 million, Kazakhstan's pharmaceutical sector is bolstered by both local production and imports, addressing the needs for a wide range of medicines, including prescription drugs, over-the-counter medications, and health supplements. The government is working to improve healthcare access, with initiatives aimed at enhancing the supply of essential drugs through the State Drug Policy and improving affordability via mandatory medical insurance and subsidy programs. The rise in chronic diseases, along with a growing preference for generic drugs, further supports the market's expansion. Retail pharmacy chains are proliferating in major cities like Almaty and Nur-Sultan, while online pharmacies are also gaining traction, improving access to medicines even in remote regions.
According to 6Wresearch, Kazakhstan Pharmacies and Drug Stores market size is projected to grow at a CAGR of 7.9% during 2025-2031. The growth of Kazakhstan's pharmacies and drug stores market is primarily driven by an expanding population, increasing urbanization, and rising awareness about health, wellness, and preventive care. The growing incidence of chronic diseases like hypertension, diabetes, and cardiovascular conditions is fuelling demand for prescription drugs and long-term treatment solutions. Additionally, the government's efforts to enhance healthcare access through initiatives like mandatory health insurance, subsidies for essential medicines, and the establishment of a more comprehensive national drug policy are positively influencing the market. The rising popularity of generic drugs, which offer more affordable alternatives to branded medications, further boosts growth.
However, the Kazakhstan Pharmacies and Drug Stores industry faces challenges such as counterfeit drugs and regulatory inefficiencies, which continue to pose risks to consumer safety and market stability. Another issue is the reliance on imported pharmaceuticals, making the market vulnerable to fluctuations in exchange rates and trade policies. Despite these challenges, the increasing penetration of retail pharmacy chains in both urban and rural areas, along with the growth of online pharmacies, is providing greater access to medications, particularly in remote regions. The market also faces competition from neighbouring countries, which impacts pricing and supply chains.
Key players in Kazakhstan's pharmacies and drug stores market include a mix of local and international pharmaceutical companies, as well as retail pharmacy chains. Prominent companies include Halyk Pharmacy, one of the largest retail pharmacy chains in the country, offering a wide range of medications and health products across its network. Europharma, a leading local pharmaceutical distributor, plays a key role in the supply of both domestic and imported medicines. Pharmapark, a prominent local pharmaceutical manufacturer, focuses on producing essential drugs, including generics, to meet growing domestic demand. International pharmaceutical companies such as Sanofi, Novartis, and Roche are also significant players, contributing to the import and distribution of high-demand prescription drugs. Additionally, some of these players hold majority of the Kazakhstan Pharmacies and Drug Stores market share.
Moreover, Kcell and Kaspi.kz have ventured into digital health services, offering online pharmaceutical sales and e-health platforms, tapping into the growing online pharmacy trend. These companies are integral to the supply chain, enhancing access to medications and contributing to the overall growth of the market.
The government of Kazakhstan has established a comprehensive regulatory framework to oversee the pharmacies and drug stores market, aimed at ensuring public health, safety, and accessibility of pharmaceuticals. The State Drug Policy focuses on regulating the registration, import, and distribution of medicines, with the Kazakhstan Medicines and Medical Devices Agency (KMDMA) overseeing drug approval processes and quality control. To combat counterfeit drugs, the government has strengthened measures for drug traceability and authentication. Additionally, the mandatory medical insurance system was introduced to improve healthcare access, including pharmaceutical coverage.
The Pharmaceutical Law mandates that drugs must meet stringent quality standards and be sold only through licensed pharmacies, while pricing regulations for essential medicines ensure affordability. Further, these initiatives have further boosted the Kazakhstan Pharmacies and Drug Stores market revenues. Furthermore, Kazakhstan is increasingly aligning its regulatory standards with international practices, especially following its integration into the Eurasian Economic Union, facilitating smoother importation and distribution of pharmaceutical products across member states.
The future of Kazakhstan's pharmacies and drug stores market looks promising, driven by several key factors including the growing demand for pharmaceuticals, an expanding middle class, and increasing healthcare awareness. With the rising prevalence of chronic diseases and an aging population, the demand for both prescription and over-the-counter medications is expected to continue to grow. The ongoing development of healthcare infrastructure, particularly in rural areas, will improve access to medicines and expand the reach of pharmacy chains. The government's push for local pharmaceutical production and the rise of online pharmacies are expected to enhance market dynamics, reducing dependency on imports while catering to a tech-savvy consumer base. Additionally, Kazakhstan's integration into the Eurasian Economic Union will further streamline pharmaceutical trade, making it easier for companies to access regional markets.
According to Ravi Bhandari, Research Head, 6Wresearch, the prescription drugs category in Kazakhstan is experiencing robust growth, primarily driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions, which require long-term medication. This growth is also supported by the increasing demand for specialty treatments in oncology, neurology, and infectious diseases. As healthcare awareness improves, patients are seeking more advanced therapies, driving the demand for prescription drugs.
The expansion of health insurance coverage and government efforts to make essential medicines more accessible have also played a significant role in boosting the category. Additionally, the rising affordability and availability of generics are contributing to the growth, as they offer cost-effective alternatives to branded drugs. With the ongoing improvements in healthcare infrastructure and an expanding urban population, the prescription drugs segment is expected to continue its upward trajectory in the coming years.
The hospital pharmacy segment in Kazakhstan is witnessing steady growth, fueled by the increasing number of healthcare facilities, the rising demand for specialized treatments, and the growing prevalence of complex medical conditions that require advanced pharmaceutical care. As hospitals expand their services, including oncology, cardiology, and intensive care, the need for specialized drugs and customized treatment regimens is growing. Furthermore, the government's efforts to improve public healthcare infrastructure and provide essential medicines under the national insurance scheme are contributing to the growth of hospital pharmacies. With a focus on quality and cost-effective medication management, hospital pharmacies are becoming key players in the healthcare system, ensuring the availability and proper administration of medications for inpatients. The growth in the hospital pharmacy sector is expected to continue, driven by both the expansion of healthcare facilities and the increasing adoption of advanced medical technologies.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kazakhstan Pharmacies and Drug Stores Market Overview |
3.1 Kazakhstan Country Macro Economic Indicators |
3.2 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, 2021 & 2031F |
3.3 Kazakhstan Pharmacies and Drug Stores Market - Industry Life Cycle |
3.4 Kazakhstan Pharmacies and Drug Stores Market - Porter's Five Forces |
3.5 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Kazakhstan Pharmacies and Drug Stores Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Kazakhstan Pharmacies and Drug Stores Market Trends |
6 Kazakhstan Pharmacies and Drug Stores Market, By Types |
6.1 Kazakhstan Pharmacies and Drug Stores Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Drug Type, 2021-2031F |
6.1.3 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Prescription Drugs, 2021-2031F |
6.1.4 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By OTC Drugs, 2021-2031F |
6.2 Kazakhstan Pharmacies and Drug Stores Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Community Pharmacy, 2021-2031F |
6.2.3 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.2.4 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Clinical Pharmacy, 2021-2031F |
6.2.5 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Industrial Pharmacy, 2021-2031F |
6.2.6 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Compounding Pharmacy, 2021-2031F |
6.2.7 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Consulting Pharmacy, 2021-2031F |
6.2.8 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2021-2031F |
6.2.9 Kazakhstan Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2021-2031F |
7 Kazakhstan Pharmacies and Drug Stores Market Import-Export Trade Statistics |
7.1 Kazakhstan Pharmacies and Drug Stores Market Export to Major Countries |
7.2 Kazakhstan Pharmacies and Drug Stores Market Imports from Major Countries |
8 Kazakhstan Pharmacies and Drug Stores Market Key Performance Indicators |
9 Kazakhstan Pharmacies and Drug Stores Market - Opportunity Assessment |
9.1 Kazakhstan Pharmacies and Drug Stores Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Kazakhstan Pharmacies and Drug Stores Market Opportunity Assessment, By Type, 2021 & 2031F |
10 Kazakhstan Pharmacies and Drug Stores Market - Competitive Landscape |
10.1 Kazakhstan Pharmacies and Drug Stores Market Revenue Share, By Companies, 2024 |
10.2 Kazakhstan Pharmacies and Drug Stores Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |